(Total Views: 178)
Posted On: 11/28/2022 10:55:52 AM
Post# of 124490
$EXAI News Article - Exscientia Receives First CTA Approval to Initiate IGNITE-AI, a Phase 1/2 Trial of EXS-21546 in Patients with Advanced Solid Tumours https://marketwirenews.com/news-releases/exsc...23021.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
